ARNI

Arno Therapeutics, IncCIK 1195116 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for ARNI PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for ARNI

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
SUSSMAN S DONALD	Other	5	$0	$0	2016-12-30
TANEN DAVID M	Secretary	6	$126.7K	$0	2016-10-03
Kariv Tomer	Director	48	$1.01M	$0	2016-08-15
Belldegrun Arie	Director	51	$756.8K	$0	2016-08-15
Zukiwski Alexander A	VP & Chief Medical Officer	15	$50.7K	$0	2016-04-07
Ruchefsky Steven B	Director	21	$1.01M	$0	2016-04-07
Reizman Yacov	Director	3	$0	$0	2016-04-07
Proniuk Stefan	VP of Product Development	11	$0	$0	2016-04-07
HAMILTON WILLIAM F PHD	Director	6	$0	$0	2016-04-07
Moorin Jay	Director	1	$0	$0	2016-01-12
KENYON LAWRENCE A	Chief Financial Officer	1	$0	$0	2014-02-24
Mattes Glenn R.	President & CEO	13	$0	$0	2014-01-24
Navins Scott L	Treasurer	1	$0	$0	2014-01-24
THURMAN RANDY H	Director	5	$5.0K	$0	2014-01-24
WEXFORD CAPITAL LP	Other	1	$0	$156	2013-10-04

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
SUSSMAN S DONALD	Other	S Sale deriv	2016-12-30	2017-01-03	1,605,809	—	$0	0	SEC↗
SUSSMAN S DONALD	Other	S Sale deriv	2016-12-30	2017-01-03	1,383,702	—	$0	0	SEC↗
SUSSMAN S DONALD	Other	S Sale	2016-12-30	2017-01-03	4,285,111	—	$0	714,285	SEC↗
TANEN DAVID M	Secretary	P Buy deriv	2016-10-03	2016-10-05	71,428	—	$0	71,428	SEC↗
TANEN DAVID M	Secretary	P Buy	2016-10-03	2016-10-05	142,857	—	$0	314,569	SEC↗
Kariv Tomer	Director	P Buy deriv	2016-08-15	2016-08-17	51,050	—	$0	51,050	SEC↗
Kariv Tomer	Director	P Buy deriv	2016-08-15	2016-08-17	131,508	—	$0	131,508	SEC↗
Kariv Tomer	Director	P Buy deriv	2016-08-15	2016-08-17	174,584	—	$0	174,584	SEC↗
Belldegrun Arie	Director	P Buy deriv	2016-08-15	2016-08-17	357,142	—	$0	357,142	SEC↗
SUSSMAN S DONALD	10% Owner	P Buy deriv	2016-08-15	2016-09-08	357,142	—	$0	357,142	SEC↗
Kariv Tomer	Director	P Buy	2016-08-15	2016-08-17	263,017	—	$0	1,277,905	SEC↗
Kariv Tomer	Director	P Buy	2016-08-15	2016-08-17	102,100	—	$0	496,068	SEC↗
Kariv Tomer	Director	P Buy	2016-08-15	2016-08-17	349,168	—	$0	1,696,495	SEC↗
Belldegrun Arie	Director	P Buy	2016-08-15	2016-08-17	714,285	—	$0	2,262,838	SEC↗
SUSSMAN S DONALD	10% Owner	P Buy	2016-08-15	2016-09-08	714,285	—	$0	714,285	SEC↗
Zukiwski Alexander A	Chief Executive Officer & CM	A Award deriv	2016-04-07	2016-04-11	1,196,070	—	$0	1,196,070	SEC↗
TANEN DAVID M	Secretary	A Award deriv	2016-04-07	2016-04-11	88,628	—	$0	88,628	SEC↗
Ruchefsky Steven B	Director	A Award deriv	2016-04-07	2016-04-11	88,628	—	$0	88,628	SEC↗
Reizman Yacov	Director	A Award deriv	2016-04-07	2016-04-11	88,628	—	$0	88,628	SEC↗
Proniuk Stefan	Chief Development Officer	A Award deriv	2016-04-07	2016-04-11	554,685	—	$0	554,685	SEC↗
HAMILTON WILLIAM F PHD	Director	A Award deriv	2016-04-07	2016-04-11	88,628	—	$0	88,628	SEC↗
Belldegrun Arie	Director	A Award deriv	2016-04-07	2016-04-11	177,256	—	$0	177,256	SEC↗
Kariv Tomer	Director	A Award deriv	2016-04-07	2016-04-15	88,628	—	$0	88,628	SEC↗
Kariv Tomer	Director	P Buy	2016-01-12	2016-04-11	707,868	$0.35	$247.8K	1,347,327	SEC↗
Kariv Tomer	Director	P Buy	2016-01-12	2016-04-11	533,208	$0.35	$186.6K	1,014,888	SEC↗
Kariv Tomer	Director	P Buy	2016-01-12	2016-04-11	206,986	$0.35	$72.4K	393,968	SEC↗
Moorin Jay	Director	A Award deriv	2016-01-12	2016-01-14	88,648	—	$0	88,648	SEC↗
Kariv Tomer	Director	P Buy	2016-01-12	2016-01-14	707,868	$0.35	$247.8K	1,347,327	SEC↗
Kariv Tomer	Director	P Buy	2016-01-12	2016-01-14	533,208	$0.35	$186.6K	1,014,888	SEC↗
Kariv Tomer	Director	P Buy	2016-01-12	2016-01-14	206,986	$0.35	$72.4K	393,968	SEC↗
Belldegrun Arie	Director	P Buy	2016-01-12	2016-01-14	714,285	$0.35	$250.0K	858,094	SEC↗
Belldegrun Arie	Director	P Buy	2016-01-12	2016-01-14	1,448,062	$0.35	$506.8K	1,548,543	SEC↗
TANEN DAVID M	Secretary	P Buy	2016-01-12	2016-01-14	362,015	$0.35	$126.7K	362,015	SEC↗
Zukiwski Alexander A	VP & Chief Medical Officer	P Buy	2016-01-12	2016-01-14	144,806	$0.35	$50.7K	261,832	SEC↗
Ruchefsky Steven B	Director	P Buy	2016-01-12	2016-01-14	2,876,633	$0.35	$1.01M	4,472,905	SEC↗
Ruchefsky Steven B	Director	A Award deriv	2015-11-04	2015-11-06	48,399	—	$0	48,399	SEC↗
Ruchefsky Steven B	Director	A Award deriv	2014-11-04	2014-11-06	136,784	—	$0	136,784	SEC↗
Ruchefsky Steven B	Director	A Award deriv	2014-10-28	2014-11-06	687,500	—	$0	687,500	SEC↗
Ruchefsky Steven B	Director	D To issuer deriv	2014-10-28	2014-11-06	687,500	—	$0	0	SEC↗
Ruchefsky Steven B	Director	D To issuer deriv	2014-10-28	2014-11-06	520,833	—	$0	0	SEC↗
Ruchefsky Steven B	Director	A Award deriv	2014-10-28	2014-11-06	520,833	—	$0	520,833	SEC↗
KENYON LAWRENCE A	Chief Financial Officer	A Award deriv	2014-02-24	2014-02-26	223,445	—	$0	223,445	SEC↗
Mattes Glenn R.	President & CEO	A Award deriv	2014-01-24	2014-01-28	408,892	—	$0	408,892	SEC↗
Navins Scott L	Treasurer	A Award deriv	2014-01-24	2014-01-28	125,457	—	$0	125,457	SEC↗
Zukiwski Alexander A	VP & Chief Medical Officer	A Award deriv	2014-01-24	2014-01-28	711,301	—	$0	711,301	SEC↗
Proniuk Stefan	VP of Product Development	A Award deriv	2014-01-24	2014-01-28	171,877	—	$0	171,877	SEC↗
HAMILTON WILLIAM F PHD	Director	A Award deriv	2014-01-24	2014-01-28	34,224	—	$0	34,224	SEC↗
Kariv Tomer	Director	A Award deriv	2014-01-24	2014-01-28	34,224	—	$0	34,224	SEC↗
Reizman Yacov	Director	A Award deriv	2014-01-24	2014-01-28	34,224	—	$0	34,224	SEC↗
Ruchefsky Steven B	Director	A Award deriv	2014-01-24	2014-01-28	34,224	—	$0	34,224	SEC↗
TANEN DAVID M	Secretary	A Award deriv	2014-01-24	2014-01-28	34,224	—	$0	34,224	SEC↗
Belldegrun Arie	Director	A Award deriv	2014-01-24	2014-01-28	68,448	—	$0	68,448	SEC↗
THURMAN RANDY H	Director	A Award deriv	2014-01-24	2014-01-29	34,224	—	$0	34,224	SEC↗
Belldegrun Arie	Director	A Award deriv	2013-11-04	2013-11-06	3,559,296	—	$0	3,559,296	SEC↗
HAMILTON WILLIAM F PHD	Director	A Award deriv	2013-11-04	2013-11-06	68,448	—	$0	68,448	SEC↗
Kariv Tomer	Director	A Award deriv	2013-11-04	2013-11-06	68,448	—	$0	68,448	SEC↗
Proniuk Stefan	VP of Product Development	A Award deriv	2013-11-04	2013-11-06	45,701	—	$0	45,701	SEC↗
Reizman Yacov	Director	A Award deriv	2013-11-04	2013-11-06	68,448	—	$0	68,448	SEC↗
Ruchefsky Steven B	Director	A Award deriv	2013-11-04	2013-11-06	205,344	—	$0	205,344	SEC↗
TANEN DAVID M	Secretary	A Award deriv	2013-11-04	2013-11-06	68,448	—	$0	68,448	SEC↗
THURMAN RANDY H	Director	A Award deriv	2013-11-04	2013-11-06	68,448	—	$0	68,448	SEC↗
Mattes Glenn R.	President & CEO	A Award deriv	2013-11-04	2013-11-06	386,697	—	$0	386,697	SEC↗
Zukiwski Alexander A	VP & Chief Medical Officer	A Award deriv	2013-11-04	2013-11-08	316,389	—	$0	316,389	SEC↗
Kariv Tomer	Director	C Conversion deriv	2013-10-29	2013-10-31	203,682	—	$0	0	SEC↗
Kariv Tomer	Director	D To issuer deriv	2013-10-29	2013-10-31	203,682	—	$0	0	SEC↗
Kariv Tomer	Director	A Award deriv	2013-10-29	2013-10-31	203,682	—	$0	203,682	SEC↗
Kariv Tomer	Director	P Buy deriv	2013-10-29	2013-10-31	203,682	—	$0	203,682	SEC↗
Kariv Tomer	Director	C Conversion deriv	2013-10-29	2013-10-31	153,426	—	$0	0	SEC↗
Kariv Tomer	Director	D To issuer deriv	2013-10-29	2013-10-31	153,426	—	$0	0	SEC↗
Kariv Tomer	Director	A Award deriv	2013-10-29	2013-10-31	153,426	—	$0	153,426	SEC↗
Kariv Tomer	Director	P Buy deriv	2013-10-29	2013-10-31	153,426	—	$0	153,426	SEC↗
Kariv Tomer	Director	P Buy deriv	2013-10-29	2013-10-31	153,426	—	$0	153,426	SEC↗
Kariv Tomer	Director	C Conversion deriv	2013-10-29	2013-10-31	59,558	—	$0	0	SEC↗
Kariv Tomer	Director	D To issuer deriv	2013-10-29	2013-10-31	59,558	—	$0	0	SEC↗
Kariv Tomer	Director	A Award deriv	2013-10-29	2013-10-31	59,558	—	$0	59,558	SEC↗
Kariv Tomer	Director	P Buy deriv	2013-10-29	2013-10-31	59,558	—	$0	59,558	SEC↗
Kariv Tomer	Director	P Buy deriv	2013-10-29	2013-10-31	59,558	—	$0	59,558	SEC↗
Kariv Tomer	Director	P Buy deriv	2013-10-29	2013-10-31	203,682	—	$0	203,682	SEC↗
Mattes Glenn R.	President & CEO	P Buy deriv	2013-10-29	2013-10-31	20,833	—	$0	20,833	SEC↗
Mattes Glenn R.	President & CEO	C Conversion deriv	2013-10-29	2013-10-31	20,833	—	$0	0	SEC↗
Mattes Glenn R.	President & CEO	D To issuer deriv	2013-10-29	2013-10-31	20,833	—	$0	0	SEC↗
Mattes Glenn R.	President & CEO	A Award deriv	2013-10-29	2013-10-31	20,833	—	$0	20,833	SEC↗
Mattes Glenn R.	President & CEO	P Buy deriv	2013-10-29	2013-10-31	20,833	—	$0	20,833	SEC↗
Ruchefsky Steven B	Director	P Buy deriv	2013-10-29	2013-10-31	687,500	—	$0	687,500	SEC↗
Ruchefsky Steven B	Director	C Conversion deriv	2013-10-29	2013-10-31	520,833	—	$0	0	SEC↗
Ruchefsky Steven B	Director	D To issuer deriv	2013-10-29	2013-10-31	520,833	—	$0	0	SEC↗
Ruchefsky Steven B	Director	A Award deriv	2013-10-29	2013-10-31	520,833	—	$0	520,833	SEC↗
Ruchefsky Steven B	Director	P Buy deriv	2013-10-29	2013-10-31	687,500	—	$0	687,500	SEC↗
Proniuk Stefan	VP of Product Development	D To issuer deriv	2013-10-29	2013-10-31	8,333	—	$0	0	SEC↗
Proniuk Stefan	VP of Product Development	A Award deriv	2013-10-29	2013-10-31	8,333	—	$0	8,333	SEC↗
Proniuk Stefan	VP of Product Development	C Conversion deriv	2013-10-29	2013-10-31	8,333	—	$0	0	SEC↗
HAMILTON WILLIAM F PHD	Director	P Buy deriv	2013-10-29	2013-10-31	20,833	—	$0	20,833	SEC↗
HAMILTON WILLIAM F PHD	Director	P Buy deriv	2013-10-29	2013-10-31	20,833	—	$0	20,833	SEC↗
Zukiwski Alexander A	VP & Chief Medical Officer	C Conversion deriv	2013-10-29	2013-10-31	62,500	—	$0	0	SEC↗
Zukiwski Alexander A	VP & Chief Medical Officer	P Buy deriv	2013-10-29	2013-10-31	41,666	—	$0	41,666	SEC↗
Zukiwski Alexander A	VP & Chief Medical Officer	A Award deriv	2013-10-29	2013-10-31	62,500	—	$0	62,500	SEC↗
Zukiwski Alexander A	VP & Chief Medical Officer	D To issuer deriv	2013-10-29	2013-10-31	62,500	—	$0	0	SEC↗
Zukiwski Alexander A	VP & Chief Medical Officer	P Buy deriv	2013-10-29	2013-10-31	41,666	—	$0	41,666	SEC↗
Belldegrun Arie	Director	P Buy deriv	2013-10-29	2013-11-05	104,166	—	$0	104,166	SEC↗
Belldegrun Arie	Director	P Buy deriv	2013-10-29	2013-11-05	187,500	—	$0	187,500	SEC↗
Belldegrun Arie	Director	A Award deriv	2013-10-29	2013-11-05	145,833	—	$0	145,833	SEC↗
Belldegrun Arie	Director	D To issuer deriv	2013-10-29	2013-11-05	145,833	—	$0	0	SEC↗
Belldegrun Arie	Director	C Conversion deriv	2013-10-29	2013-11-05	145,833	—	$0	0	SEC↗
Belldegrun Arie	Director	P Buy deriv	2013-10-29	2013-11-05	104,166	—	$0	104,166	SEC↗
Belldegrun Arie	Director	P Buy deriv	2013-10-29	2013-11-05	187,500	—	$0	187,500	SEC↗
Belldegrun Arie	Director	A Award deriv	2013-10-29	2013-11-05	125,000	—	$0	125,000	SEC↗
Belldegrun Arie	Director	D To issuer deriv	2013-10-29	2013-11-05	125,000	—	$0	0	SEC↗
Belldegrun Arie	Director	C Conversion deriv	2013-10-29	2013-11-05	125,000	—	$0	0	SEC↗
Belldegrun Arie	Director	P Buy deriv	2013-10-29	2013-11-05	104,166	—	$0	104,166	SEC↗
Belldegrun Arie	Director	P Buy deriv	2013-10-29	2013-11-05	104,166	—	$0	104,166	SEC↗
Belldegrun Arie	Director	A Award deriv	2013-10-29	2013-11-05	83,333	—	$0	83,333	SEC↗
Belldegrun Arie	Director	D To issuer deriv	2013-10-29	2013-11-05	83,333	—	$0	0	SEC↗
Belldegrun Arie	Director	C Conversion deriv	2013-10-29	2013-11-05	83,333	—	$0	0	SEC↗
Belldegrun Arie	Director	P Buy deriv	2013-10-29	2013-11-05	83,333	—	$0	83,333	SEC↗
Belldegrun Arie	Director	P Buy deriv	2013-10-29	2013-11-05	83,333	—	$0	83,333	SEC↗
Belldegrun Arie	Director	A Award deriv	2013-10-29	2013-11-05	62,500	—	$0	62,500	SEC↗
Belldegrun Arie	Director	D To issuer deriv	2013-10-29	2013-11-05	62,500	—	$0	0	SEC↗
Belldegrun Arie	Director	C Conversion deriv	2013-10-29	2013-11-05	62,500	—	$0	0	SEC↗
Kariv Tomer	Director	P Buy	2013-10-29	2013-10-31	153,426	—	$0	481,680	SEC↗
Kariv Tomer	Director	A Award	2013-10-29	2013-10-31	12,274	$2.40	$29.5K	328,254	SEC↗
Kariv Tomer	Director	C Conversion	2013-10-29	2013-10-31	163,620	$2.40	$392.7K	315,980	SEC↗
Kariv Tomer	Director	P Buy	2013-10-29	2013-10-31	203,682	—	$0	639,459	SEC↗
Kariv Tomer	Director	A Award	2013-10-29	2013-10-31	16,294	$2.40	$39.1K	435,777	SEC↗
Kariv Tomer	Director	C Conversion	2013-10-29	2013-10-31	217,216	$2.40	$521.3K	419,483	SEC↗
Kariv Tomer	Director	C Conversion	2013-10-29	2013-10-31	63,516	$2.40	$152.4K	122,660	SEC↗
Kariv Tomer	Director	A Award	2013-10-29	2013-10-31	4,764	$2.40	$11.4K	127,424	SEC↗
Kariv Tomer	Director	P Buy	2013-10-29	2013-10-31	59,558	—	$0	186,982	SEC↗
Mattes Glenn R.	President & CEO	A Award	2013-10-29	2013-10-31	1,666	$2.40	$4.0K	56,370	SEC↗
Mattes Glenn R.	President & CEO	P Buy	2013-10-29	2013-10-31	20,833	—	$0	77,203	SEC↗
Mattes Glenn R.	President & CEO	C Conversion	2013-10-29	2013-10-31	22,218	$2.40	$53.3K	54,704	SEC↗
Ruchefsky Steven B	Director	A Award	2013-10-29	2013-10-31	41,666	$2.40	$100.0K	1,596,272	SEC↗
Ruchefsky Steven B	Director	P Buy	2013-10-29	2013-10-31	687,500	—	$0	1,554,606	SEC↗
Ruchefsky Steven B	Director	C Conversion	2013-10-29	2013-10-31	555,440	$2.40	$1.33M	867,106	SEC↗
Proniuk Stefan	VP of Product Development	A Award	2013-10-29	2013-10-31	666	$2.40	$1.6K	10,047	SEC↗
Proniuk Stefan	VP of Product Development	C Conversion	2013-10-29	2013-10-31	8,887	$2.40	$21.3K	9,381	SEC↗
HAMILTON WILLIAM F PHD	Director	P Buy	2013-10-29	2013-10-31	20,833	—	$0	22,079	SEC↗
Zukiwski Alexander A	VP & Chief Medical Officer	C Conversion	2013-10-29	2013-10-31	66,652	$2.40	$160.0K	70,360	SEC↗
Zukiwski Alexander A	VP & Chief Medical Officer	P Buy	2013-10-29	2013-10-31	41,666	—	$0	117,026	SEC↗
Zukiwski Alexander A	VP & Chief Medical Officer	A Award	2013-10-29	2013-10-31	5,000	$2.40	$12.0K	75,360	SEC↗
Belldegrun Arie	Director	P Buy	2013-10-29	2013-11-05	104,166	—	$0	254,887	SEC↗
Belldegrun Arie	Director	P Buy	2013-10-29	2013-11-05	104,166	—	$0	143,809	SEC↗
Belldegrun Arie	Director	C Conversion	2013-10-29	2013-11-05	133,305	$2.40	$319.9K	140,721	SEC↗
Belldegrun Arie	Director	A Award	2013-10-29	2013-11-05	10,000	$2.40	$24.0K	150,721	SEC↗
Belldegrun Arie	Director	C Conversion	2013-10-29	2013-11-05	155,523	$2.40	$373.3K	180,128	SEC↗
Belldegrun Arie	Director	A Award	2013-10-29	2013-11-05	11,666	$2.40	$28.0K	191,794	SEC↗
Belldegrun Arie	Director	P Buy	2013-10-29	2013-11-05	187,500	—	$0	379,294	SEC↗
Belldegrun Arie	Director	A Award	2013-10-29	2013-11-05	6,666	$2.40	$16.0K	100,481	SEC↗
Belldegrun Arie	Director	C Conversion	2013-10-29	2013-11-05	66,652	$2.40	$160.0K	86,312	SEC↗
Belldegrun Arie	Director	C Conversion	2013-10-29	2013-11-05	88,871	$2.40	$213.3K	93,815	SEC↗
Belldegrun Arie	Director	A Award	2013-10-29	2013-11-05	5,000	$2.40	$12.0K	91,312	SEC↗
Belldegrun Arie	Director	P Buy	2013-10-29	2013-11-05	83,332	—	$0	174,644	SEC↗
WEXFORD CAPITAL LP	Other	S Sale	2013-10-04	2013-10-09	325	$0.48	$156	2,827,844	SEC↗
Mattes Glenn R.	President & CEO	J Other	2013-05-28	2013-05-30	3,222	$0.30	$967	259,888	SEC↗
Proniuk Stefan	VP of Product Development	J Other	2013-05-28	2013-05-30	1,289	$0.30	$387	3,955	SEC↗
Zukiwski Alexander A	VP & Chief Medical Officer	J Other	2013-05-28	2013-05-30	9,667	$0.30	$2.9K	29,667	SEC↗
Belldegrun Arie	Director	J Other	2013-05-28	2013-06-03	22,556	$0.30	$6.8K	196,841	SEC↗
Belldegrun Arie	Director	J Other	2013-05-28	2013-06-03	12,889	$0.30	$3.9K	39,555	SEC↗
Belldegrun Arie	Director	J Other	2013-05-28	2013-06-03	9,667	$0.30	$2.9K	157,286	SEC↗
Belldegrun Arie	Director	J Other	2013-05-28	2013-06-03	19,333	$0.30	$5.8K	59,333	SEC↗
Ruchefsky Steven B	Director	J Other	2013-05-28	2013-06-04	80,556	$0.30	$24.2K	2,493,331	SEC↗
Kariv Tomer	Director	J Other	2013-05-28	2013-06-05	9,529	$0.30	$2.9K	473,156	SEC↗
Kariv Tomer	Director	J Other	2013-05-28	2013-06-05	24,548	$0.30	$7.4K	1,218,883	SEC↗
Kariv Tomer	Director	J Other	2013-05-28	2013-06-05	32,589	$0.30	$9.8K	1,618,140	SEC↗
THURMAN RANDY H	Director	P Buy	2013-05-22	2013-05-23	2,500	$0.50	$1.3K	10,000	SEC↗
THURMAN RANDY H	Director	P Buy	2013-05-21	2013-05-23	7,500	$0.50	$3.8K	7,500	SEC↗
Proniuk Stefan	VP of Product Development	J Other	2013-04-29	2013-05-06	1,333	$0.30	$400	2,666	SEC↗
Kariv Tomer	Director	J Other	2013-04-29	2013-05-07	16,291	$0.30	$4.9K	463,627	SEC↗
Kariv Tomer	Director	J Other	2013-04-29	2013-05-07	41,967	$0.30	$12.6K	1,194,335	SEC↗
Kariv Tomer	Director	J Other	2013-04-29	2013-05-07	55,714	$0.30	$16.7K	1,585,551	SEC↗
Zukiwski Alexander A	VP & Chief Medical Officer	J Other	2013-04-29	2013-05-07	10,000	$0.30	$3.0K	20,000	SEC↗
Mattes Glenn R.	President & CEO	J Other	2013-04-29	2013-05-07	3,333	$0.30	$1000	256,666	SEC↗
Belldegrun Arie	Director	J Other	2013-04-29	2013-05-07	20,000	$0.30	$6.0K	40,000	SEC↗
Belldegrun Arie	Director	J Other	2013-04-29	2013-05-07	23,333	$0.30	$7.0K	174,285	SEC↗
Belldegrun Arie	Director	J Other	2013-04-29	2013-05-07	10,000	$0.30	$3.0K	147,619	SEC↗
Belldegrun Arie	Director	J Other	2013-04-29	2013-05-07	13,333	$0.30	$4.0K	26,666	SEC↗
Ruchefsky Steven B	Director	J Other	2013-04-29	2013-05-07	83,333	$0.30	$25.0K	2,412,775	SEC↗
Mattes Glenn R.	President & CEO	J Other	2013-03-27	2013-04-09	3,333	$0.30	$1000	253,333	SEC↗
Ruchefsky Steven B	Director	J Other	2013-03-27	2013-04-09	83,333	$0.30	$25.0K	2,329,442	SEC↗
Kariv Tomer	Director	J Other	2013-03-27	2013-04-10	9,529	$0.30	$2.9K	447,336	SEC↗
Kariv Tomer	Director	J Other	2013-03-27	2013-04-10	32,589	$0.30	$9.8K	1,529,837	SEC↗
Kariv Tomer	Director	J Other	2013-03-27	2013-04-10	24,548	$0.30	$7.4K	1,152,368	SEC↗
Proniuk Stefan	VP of Product Development	J Other	2013-03-27	2013-04-10	1,333	$0.30	$400	1,333	SEC↗
Zukiwski Alexander A	VP & Chief Medical Officer	J Other	2013-03-27	2013-04-11	10,000	$0.30	$3.0K	10,000	SEC↗
Belldegrun Arie	Director	J Other	2013-03-27	2013-04-15	20,000	$0.30	$6.0K	20,000	SEC↗
Belldegrun Arie	Director	J Other	2013-03-27	2013-04-15	23,333	$0.30	$7.0K	150,952	SEC↗
Belldegrun Arie	Director	J Other	2013-03-27	2013-04-15	13,333	$0.30	$4.0K	13,333	SEC↗
Belldegrun Arie	Director	J Other	2013-03-27	2013-04-15	10,000	$0.30	$3.0K	137,619	SEC↗
THURMAN RANDY H	Director	A Award deriv	2013-01-30	2013-02-01	200,000	—	$0	200,000	SEC↗